Dr Michael Weller is Chairman of the Department of Neurology at the University Hospital in Zurich, Switzerland.
The focus of his practice and research is the diagnosis and treatment of brain tumors, including immunotherapy, and has been involved in major practice-changing clinical trials including the registration trial for temozolomide in glioblastoma.
He has received several awards in recognition of his important contributions to cancer research, including the German Cancer Award in 2007. He has co-authored more than 550 original publications in peer-reviewed journals and is on the Executive Board of the European Association for Neuro-Oncology (EANO), serving as President of EANO from 2014–2016.